Search

Your search keyword '"Scarlatti, Gabriella"' showing total 489 results

Search Constraints

Start Over You searched for: Author "Scarlatti, Gabriella" Remove constraint Author: "Scarlatti, Gabriella"
489 results on '"Scarlatti, Gabriella"'

Search Results

1. Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens

2. Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial

5. Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers

6. Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization

7. Innate cell markers that predict anti-HIV neutralizing antibody titers in vaccinated macaques

9. HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.

10. COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain

13. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

14. Ex vivo challenge models for infectious diseases

15. Evaluation of a human mucosal tissue explant model for SARS-CoV-2 replication

19. Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia

20. The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age

21. Human seminal plasma stimulates the migration of CD11c+ mononuclear phagocytes to the apical side of the colonic epithelium without altering the junctional complexes in an ex vivo human intestinal model

22. Recent progress in immune-based interventions to prevent HIV-1 transmission to children

24. Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention

26. Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence

27. The immunological profile of SARS-CoV-2 infection in children is linked to clinical severity and age

30. A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model

31. Dichotomy in Neutralizing Antibody Induction to Peptide-Conjugated Vaccine in Squalene Emulsion Contrast With Aluminum Hydroxide Formulation

34. Persistent Immunogenicity of Integrase Defective Lentiviral Vectors delivering membrane tethered Native-Like HIV-1 Envelope Trimers

35. Eliminating HIV transmission through breast milk from women taking antiretroviral drugs

37. Prognostic Value of the Stromal Cell-Derived Factor 1 3′A Mutation in Pediatric Human Immunodeficiency Virus Type 1 Infection

38. Seasonal betacoronavirus antibodies expansion post BNT161b2 vaccination associates with reduced SARS-CoV-2 VoCs neutralization

39. Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens

44. Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions

47. COVID-BioB Cohort Study: the neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survival

48. Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia

49. Innate Cell Markers That Predict Anti-HIV Neutralizing Antibody Titers in Vaccinated Macaques

50. Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization

Catalog

Books, media, physical & digital resources